These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3314019)

  • 21. Sequential use of antithymocyte globulin and cyclosporine augments skin allograft survival.
    Thomas J; Whitley T; Carver M; Thomas F
    Transplant Proc; 1984 Dec; 16(6):1522-4. PubMed ID: 6390858
    [No Abstract]   [Full Text] [Related]  

  • 22. Total lymphoid irradiation in rat heart allografts: dose, fractionation, and combination with cyclosporin-A.
    Rynasiewicz JJ; Sutherland DE; Kawahara K; Kim T; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):452-4. PubMed ID: 7022872
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heart transplantation].
    Hetzer R; Warnecke H; Schüler S; Süthoff U; Wonigeit K; Lang W; Herrmann G; Hepp A; Schaps D; Borst HG
    Internist (Berl); 1985 Sep; 26(9):563-8. PubMed ID: 3905678
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 25. Preformed lymphocytotoxic antibodies disappear following cyclosporine therapy.
    Novitzky D; Cooper DK; Du Toit E; Oudshoorn M; Langman E; Jacobs P
    J Heart Transplant; 1985 May; 4(3):362-3. PubMed ID: 3916509
    [No Abstract]   [Full Text] [Related]  

  • 26. A brief course of cyclosporine A pretransplant reduces posttransplant cyclosporine A requirements in beagles and humans.
    Burke G; Esquenazi V; Milgrom M; Fuller L; Roth D; Olson L; Miller J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):478-80. PubMed ID: 3363650
    [No Abstract]   [Full Text] [Related]  

  • 27. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats.
    Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y
    Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolongation of rat skin and cardiac allograft survival by low molecular weight heparin.
    Shapira OM; Rene H; Lider O; Pfeffermann RA; Shemin RJ; Cohen IR
    J Surg Res; 1999 Jul; 85(1):83-7. PubMed ID: 10383842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new rat infection-heart transplant model: effect of infection on graft survival studies.
    Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
    J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleotide-free diet and suppression of immune response.
    Van Buren CT; Kim E; Kulkarni AD; Fanslow WC; Rudolph FB
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):57-9. PubMed ID: 3303568
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
    den Dulk M; Wang C; Li J; Clark DA; Hibberd AD; Terpstra OT; McCaughan GW; Bishop GA
    Transpl Immunol; 2004 Nov; 13(3):177-84. PubMed ID: 15381200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged survival of cardiac xenografts between widely divergent species: bird to mammal.
    Braidley PC; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):307-8. PubMed ID: 7879013
    [No Abstract]   [Full Text] [Related]  

  • 33. LF 15-0195, a novel immunosuppressive agent prevents rejection and induces operational tolerance in a mouse cardiac allograft model.
    Zhou D; O'Brien C; Shum J; Garcia B; Min W; Jevnikar AM; Dutartre P; Zhong R
    Transplantation; 2003 Aug; 76(4):644-50. PubMed ID: 12973102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin-A-induced long-term survival of fully incompatible skin and heart grafts in rats.
    White DJ; Rolles K; Ottawa T; Turell O
    Transplant Proc; 1980 Jun; 12(2):261-5. PubMed ID: 6994294
    [No Abstract]   [Full Text] [Related]  

  • 35. [Indefinite survival of pancreatic allografts under cyclosporin A treatment in rats].
    Domergue J; Bouhaddioui N; Barneon G; Marchal G
    J Chir (Paris); 1984 Mar; 121(3):195-201. PubMed ID: 6373804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between dose and level of cyclosporine after orthotopic liver transplantation.
    Kahn D; Mazzaferro V; Cervio G; Venkataramanan R; Makowka L; Van Thiel DH; Starzl TE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2240-1. PubMed ID: 2652726
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C; Heemann U; Azuma H; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
    [No Abstract]   [Full Text] [Related]  

  • 39. Segmental pancreatic allograft survival in baboons treated with combined irradiation and cyclosporine: a preliminary report.
    du Toit DF; Heydenrych JJ; Smit B; Louw G; Zuurmond T; Laker L; Els D; Weideman A; Wolfe-Coote S; van der Merwe EA
    Surgery; 1985 Apr; 97(4):447-54. PubMed ID: 3885455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of long-term graft tolerance and donor/recipient chimerism.
    Fisher RA; Cohen DS; Ben-Ezra JM; Sallade RE; Tawes JW; Tarry WC
    J Surg Res; 1996 Jan; 60(1):181-5. PubMed ID: 8592412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.